Global Iguratimod Market Growth 2023-2029

March 2023 | 78 pages | ID: GFE87E6CAC5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Iguratimod Industry Forecast” looks at past sales and reviews total world Iguratimod sales in 2022, providing a comprehensive analysis by region and market sector of projected Iguratimod sales for 2023 through 2029. With Iguratimod sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iguratimod industry.

This Insight Report provides a comprehensive analysis of the global Iguratimod landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iguratimod portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Iguratimod market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iguratimod and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iguratimod.

The global Iguratimod market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Iguratimod is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Iguratimod is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Iguratimod is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Iguratimod players cover Simcere Pharmaceutical, Toyama Chemical and Eisai, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Iguratimod market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 14 Pcs/Box
• 100 Pcs/Box

Segmentation by application

• Antirheumatic
• Immunoregulation
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Simcere Pharmaceutical
• Toyama Chemical
• Eisai

Key Questions Addressed in this Report

What is the 10-year outlook for the global Iguratimod market?

What factors are driving Iguratimod market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Iguratimod market opportunities vary by end market size?

How does Iguratimod break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Iguratimod Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Iguratimod by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Iguratimod by Country/Region, 2018, 2022 & 2029
2.2 Iguratimod Segment by Type
  2.2.1 14 Pcs/Box
  2.2.2 100 Pcs/Box
2.3 Iguratimod Sales by Type
  2.3.1 Global Iguratimod Sales Market Share by Type (2018-2023)
  2.3.2 Global Iguratimod Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Iguratimod Sale Price by Type (2018-2023)
2.4 Iguratimod Segment by Application
  2.4.1 Antirheumatic
  2.4.2 Immunoregulation
  2.4.3 Other
2.5 Iguratimod Sales by Application
  2.5.1 Global Iguratimod Sale Market Share by Application (2018-2023)
  2.5.2 Global Iguratimod Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Iguratimod Sale Price by Application (2018-2023)

3 GLOBAL IGURATIMOD BY COMPANY

3.1 Global Iguratimod Breakdown Data by Company
  3.1.1 Global Iguratimod Annual Sales by Company (2018-2023)
  3.1.2 Global Iguratimod Sales Market Share by Company (2018-2023)
3.2 Global Iguratimod Annual Revenue by Company (2018-2023)
  3.2.1 Global Iguratimod Revenue by Company (2018-2023)
  3.2.2 Global Iguratimod Revenue Market Share by Company (2018-2023)
3.3 Global Iguratimod Sale Price by Company
3.4 Key Manufacturers Iguratimod Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Iguratimod Product Location Distribution
  3.4.2 Players Iguratimod Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR IGURATIMOD BY GEOGRAPHIC REGION

4.1 World Historic Iguratimod Market Size by Geographic Region (2018-2023)
  4.1.1 Global Iguratimod Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Iguratimod Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Iguratimod Market Size by Country/Region (2018-2023)
  4.2.1 Global Iguratimod Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Iguratimod Annual Revenue by Country/Region (2018-2023)
4.3 Americas Iguratimod Sales Growth
4.4 APAC Iguratimod Sales Growth
4.5 Europe Iguratimod Sales Growth
4.6 Middle East & Africa Iguratimod Sales Growth

5 AMERICAS

5.1 Americas Iguratimod Sales by Country
  5.1.1 Americas Iguratimod Sales by Country (2018-2023)
  5.1.2 Americas Iguratimod Revenue by Country (2018-2023)
5.2 Americas Iguratimod Sales by Type
5.3 Americas Iguratimod Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Iguratimod Sales by Region
  6.1.1 APAC Iguratimod Sales by Region (2018-2023)
  6.1.2 APAC Iguratimod Revenue by Region (2018-2023)
6.2 APAC Iguratimod Sales by Type
6.3 APAC Iguratimod Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Iguratimod by Country
  7.1.1 Europe Iguratimod Sales by Country (2018-2023)
  7.1.2 Europe Iguratimod Revenue by Country (2018-2023)
7.2 Europe Iguratimod Sales by Type
7.3 Europe Iguratimod Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Iguratimod by Country
  8.1.1 Middle East & Africa Iguratimod Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Iguratimod Revenue by Country (2018-2023)
8.2 Middle East & Africa Iguratimod Sales by Type
8.3 Middle East & Africa Iguratimod Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iguratimod
10.3 Manufacturing Process Analysis of Iguratimod
10.4 Industry Chain Structure of Iguratimod

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Iguratimod Distributors
11.3 Iguratimod Customer

12 WORLD FORECAST REVIEW FOR IGURATIMOD BY GEOGRAPHIC REGION

12.1 Global Iguratimod Market Size Forecast by Region
  12.1.1 Global Iguratimod Forecast by Region (2024-2029)
  12.1.2 Global Iguratimod Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Iguratimod Forecast by Type
12.7 Global Iguratimod Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Simcere Pharmaceutical
  13.1.1 Simcere Pharmaceutical Company Information
  13.1.2 Simcere Pharmaceutical Iguratimod Product Portfolios and Specifications
  13.1.3 Simcere Pharmaceutical Iguratimod Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Simcere Pharmaceutical Main Business Overview
  13.1.5 Simcere Pharmaceutical Latest Developments
13.2 Toyama Chemical
  13.2.1 Toyama Chemical Company Information
  13.2.2 Toyama Chemical Iguratimod Product Portfolios and Specifications
  13.2.3 Toyama Chemical Iguratimod Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Toyama Chemical Main Business Overview
  13.2.5 Toyama Chemical Latest Developments
13.3 Eisai
  13.3.1 Eisai Company Information
  13.3.2 Eisai Iguratimod Product Portfolios and Specifications
  13.3.3 Eisai Iguratimod Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Eisai Main Business Overview
  13.3.5 Eisai Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Iguratimod Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Iguratimod Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 14 Pcs/Box
Table 4. Major Players of 100 Pcs/Box
Table 5. Global Iguratimod Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Iguratimod Sales Market Share by Type (2018-2023)
Table 7. Global Iguratimod Revenue by Type (2018-2023) & ($ million)
Table 8. Global Iguratimod Revenue Market Share by Type (2018-2023)
Table 9. Global Iguratimod Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Iguratimod Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Iguratimod Sales Market Share by Application (2018-2023)
Table 12. Global Iguratimod Revenue by Application (2018-2023)
Table 13. Global Iguratimod Revenue Market Share by Application (2018-2023)
Table 14. Global Iguratimod Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Iguratimod Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Iguratimod Sales Market Share by Company (2018-2023)
Table 17. Global Iguratimod Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Iguratimod Revenue Market Share by Company (2018-2023)
Table 19. Global Iguratimod Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Iguratimod Producing Area Distribution and Sales Area
Table 21. Players Iguratimod Products Offered
Table 22. Iguratimod Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Iguratimod Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Iguratimod Sales Market Share Geographic Region (2018-2023)
Table 27. Global Iguratimod Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Iguratimod Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Iguratimod Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Iguratimod Sales Market Share by Country/Region (2018-2023)
Table 31. Global Iguratimod Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Iguratimod Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Iguratimod Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Iguratimod Sales Market Share by Country (2018-2023)
Table 35. Americas Iguratimod Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Iguratimod Revenue Market Share by Country (2018-2023)
Table 37. Americas Iguratimod Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Iguratimod Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Iguratimod Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Iguratimod Sales Market Share by Region (2018-2023)
Table 41. APAC Iguratimod Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Iguratimod Revenue Market Share by Region (2018-2023)
Table 43. APAC Iguratimod Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Iguratimod Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Iguratimod Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Iguratimod Sales Market Share by Country (2018-2023)
Table 47. Europe Iguratimod Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Iguratimod Revenue Market Share by Country (2018-2023)
Table 49. Europe Iguratimod Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Iguratimod Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Iguratimod Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Iguratimod Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Iguratimod Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Iguratimod Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Iguratimod Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Iguratimod Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Iguratimod
Table 58. Key Market Challenges & Risks of Iguratimod
Table 59. Key Industry Trends of Iguratimod
Table 60. Iguratimod Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Iguratimod Distributors List
Table 63. Iguratimod Customer List
Table 64. Global Iguratimod Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Iguratimod Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Iguratimod Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Iguratimod Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Iguratimod Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Iguratimod Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Iguratimod Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Iguratimod Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Iguratimod Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Iguratimod Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Iguratimod Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Iguratimod Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Iguratimod Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Iguratimod Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Simcere Pharmaceutical Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 79. Simcere Pharmaceutical Iguratimod Product Portfolios and Specifications
Table 80. Simcere Pharmaceutical Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Simcere Pharmaceutical Main Business
Table 82. Simcere Pharmaceutical Latest Developments
Table 83. Toyama Chemical Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 84. Toyama Chemical Iguratimod Product Portfolios and Specifications
Table 85. Toyama Chemical Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. Toyama Chemical Main Business
Table 87. Toyama Chemical Latest Developments
Table 88. Eisai Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 89. Eisai Iguratimod Product Portfolios and Specifications
Table 90. Eisai Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 91. Eisai Main Business
Table 92. Eisai Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Iguratimod
Figure 2. Iguratimod Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iguratimod Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Iguratimod Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Iguratimod Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 14 Pcs/Box
Figure 10. Product Picture of 100 Pcs/Box
Figure 11. Global Iguratimod Sales Market Share by Type in 2022
Figure 12. Global Iguratimod Revenue Market Share by Type (2018-2023)
Figure 13. Iguratimod Consumed in Antirheumatic
Figure 14. Global Iguratimod Market: Antirheumatic (2018-2023) & (K Pcs)
Figure 15. Iguratimod Consumed in Immunoregulation
Figure 16. Global Iguratimod Market: Immunoregulation (2018-2023) & (K Pcs)
Figure 17. Iguratimod Consumed in Other
Figure 18. Global Iguratimod Market: Other (2018-2023) & (K Pcs)
Figure 19. Global Iguratimod Sales Market Share by Application (2022)
Figure 20. Global Iguratimod Revenue Market Share by Application in 2022
Figure 21. Iguratimod Sales Market by Company in 2022 (K Pcs)
Figure 22. Global Iguratimod Sales Market Share by Company in 2022
Figure 23. Iguratimod Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Iguratimod Revenue Market Share by Company in 2022
Figure 25. Global Iguratimod Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Iguratimod Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Iguratimod Sales 2018-2023 (K Pcs)
Figure 28. Americas Iguratimod Revenue 2018-2023 ($ Millions)
Figure 29. APAC Iguratimod Sales 2018-2023 (K Pcs)
Figure 30. APAC Iguratimod Revenue 2018-2023 ($ Millions)
Figure 31. Europe Iguratimod Sales 2018-2023 (K Pcs)
Figure 32. Europe Iguratimod Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Iguratimod Sales 2018-2023 (K Pcs)
Figure 34. Middle East & Africa Iguratimod Revenue 2018-2023 ($ Millions)
Figure 35. Americas Iguratimod Sales Market Share by Country in 2022
Figure 36. Americas Iguratimod Revenue Market Share by Country in 2022
Figure 37. Americas Iguratimod Sales Market Share by Type (2018-2023)
Figure 38. Americas Iguratimod Sales Market Share by Application (2018-2023)
Figure 39. United States Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Iguratimod Sales Market Share by Region in 2022
Figure 44. APAC Iguratimod Revenue Market Share by Regions in 2022
Figure 45. APAC Iguratimod Sales Market Share by Type (2018-2023)
Figure 46. APAC Iguratimod Sales Market Share by Application (2018-2023)
Figure 47. China Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Iguratimod Sales Market Share by Country in 2022
Figure 55. Europe Iguratimod Revenue Market Share by Country in 2022
Figure 56. Europe Iguratimod Sales Market Share by Type (2018-2023)
Figure 57. Europe Iguratimod Sales Market Share by Application (2018-2023)
Figure 58. Germany Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Iguratimod Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Iguratimod Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Iguratimod Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Iguratimod Sales Market Share by Application (2018-2023)
Figure 67. Egypt Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Iguratimod Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Iguratimod in 2022
Figure 73. Manufacturing Process Analysis of Iguratimod
Figure 74. Industry Chain Structure of Iguratimod
Figure 75. Channels of Distribution
Figure 76. Global Iguratimod Sales Market Forecast by Region (2024-2029)
Figure 77. Global Iguratimod Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Iguratimod Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Iguratimod Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Iguratimod Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Iguratimod Revenue Market Share Forecast by Application (2024-2029)